Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Mediwound stock

Learn how to easily invest in Mediwound stock.

Mediwound is a biotechnology business based in the US. Mediwound shares (MDWD) are listed on the NASDAQ and all prices are listed in US Dollars. Mediwound employs 77 staff and has a trailing 12-month revenue of around $20.4 million.

How to buy Mediwound stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – MDWD. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Mediwound stock price (NASDAQ: MDWD)

Use our graph to track the performance of MDWD stocks over time.

Mediwound shares at a glance

Information last updated 2023-01-26.
Latest market close$14.17
52-week range$8.05 - $17.75
50-day moving average $11.40
200-day moving average $12.02
Wall St. target price$40.17
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.52

Buy Mediwound stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Mediwound stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Mediwound price performance over time

Historical closes compared with the close of $14.17 from 2023-01-27

1 week (2023-01-23) 5.90%
1 month (2022-12-30) 5.04%
3 months (2022-10-31) 965.41%
6 months (2022-07-29) 748.50%
1 year (2022-01-31) 469.08%
2 years (2021-01-29) 193.37%
3 years (2020-01-31) 367.66%
5 years (2018-01-30) 209.73%

Mediwound financials

Revenue TTM $20.4 million
Gross profit TTM $8.8 million
Return on assets TTM -33.04%
Return on equity TTM -3904.67%
Profit margin -80.05%
Book value $0.29
Market capitalisation $79.2 million

TTM: trailing 12 months

Mediwound share dividends

We're not expecting Mediwound to pay a dividend over the next 12 months.

Have Mediwound's shares ever split?

Mediwound's shares were split on a 1:7 basis on 19 December 2022. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Mediwound shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Mediwound shares which in turn could have impacted Mediwound's share price.

Mediwound share price volatility

Over the last 12 months, Mediwound's shares have ranged in value from as little as $8.05 up to $17.745. A popular way to gauge a stock's volatility is its "beta".

MDWD.US volatility(beta: 1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mediwound's is 1.0045. This would suggest that Mediwound's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Mediwound overview

MediWound Ltd. , a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel. .

Frequently asked questions

What percentage of Mediwound is owned by insiders or institutions?
Currently 39.273% of Mediwound shares are held by insiders and 36.026% by institutions.
How many people work for Mediwound?
Latest data suggests 77 work at Mediwound.
When does the fiscal year end for Mediwound?
Mediwound's fiscal year ends in December.
Where is Mediwound based?
Mediwound's address is: 42 Hayarkon Street, Yavne, Israel, 8122745
What is Mediwound's ISIN number?
Mediwound's international securities identification number is: IL0011316309
What is Mediwound's CUSIP number?
Mediwound's Committee on Uniform Securities Identification Procedures number is: M68830104

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site